Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in japanese patients with relapsing remitting multiple sclerosis
Conclusions The results of this 2-year study demonstrate that IM IFN beta-1a can be used effectively and safely in Japanese patients with relapsing remitting multiple sclerosis for an extended period of time.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Avonex | Common Cold | Disability | Influenza | Multiple Sclerosis | Neurology | Rebif | Study